...
首页> 外文期刊>Inflammatory bowel diseases >Treatment Failure of TNF-alpha Inhibitors in Obese Patients With Inflammatory Bowel Disease-A Cohort Study
【24h】

Treatment Failure of TNF-alpha Inhibitors in Obese Patients With Inflammatory Bowel Disease-A Cohort Study

机译:TNF-α抑制剂在肥胖症患者炎症性肠病 - 群组研究中的治疗失败

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: In treatment of inflammatory bowel disease (IBD) with anti-tumor necrosis factor-alpha agents (anti-TNF-alpha), obesity has been suspected as a cause of accelerated loss of response (LOR). We sought to determine whether overweight IBD patients have accelerated LOR when treated with anti-TNF-alpha agents, compared with normal weight IBD patients.
机译:背景:在用抗肿瘤坏死因子 - α剂(抗TNF-α)治疗炎症性肠病(IBD),肥胖被怀疑被怀疑是加速丧失反应丧失(LOR)的原因。 与抗TNF-α剂处理相比,我们试图确定超重IBD患者是否在抗TNF-α剂处理时具有加速的LOR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号